Rifabutin and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rifabutin (rifabutin) and Meropenem (meropenem). Common drug interactions include cataract among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Rifabutin and Meropenem. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Rifabutin?

Rifabutin has active ingredients of rifabutin. eHealthMe is studying from 2,437 Rifabutin users. Check the latest studies of Rifabutin.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

On Jul, 16, 2026

52 people who take Rifabutin and Meropenem together, and have interactions are studied.

Rifabutin and Meropenem drug interactions.

What are the common drug interactions of Rifabutin and Meropenem, by gender? *:

female:

Cataract (clouding of the lens inside the eye)
Deposit eye (yellow or white deposits in eyes)
Mycobacterial infection
Pathogen resistance
Retinal disorder (disease of retina)
Fatigue (feeling of tiredness)
Leukocytosis (increased white blood cells)
Pyrexia (fever)
Corneal pigmentation (colour of cornea)
Device expulsion

male:

Neutropenia (an abnormally low number of neutrophils)
Electrocardiogram qt prolonged
Drug resistance (reduction in effectiveness of a drug)
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hyperkalaemia (damage to or disease of the kidney)
Hypokalaemia (low potassium)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
Arthralgia (joint pain)

What are the common drug interactions of Rifabutin and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Electrocardiogram qt prolonged
Renal failure acute (rapid kidney dysfunction)
Drug level below therapeutic
Immunosuppressant drug level decreased
Diarrhoea

20-29:

Drug resistance (reduction in effectiveness of a drug)
Electrocardiogram t wave inversion

30-39:

Electrocardiogram qt prolonged
Pathogen resistance
Anaemia (lack of blood)
Arthralgia (joint pain)
Mycobacterial infection
Nausea (feeling of having an urge to vomit)
Drug resistance (reduction in effectiveness of a drug)
Fatigue (feeling of tiredness)
Leukocytosis (increased white blood cells)
Nephropathy toxic (damage to kidney due to toxins)

40-49:

Cataract (clouding of the lens inside the eye)
Deposit eye (yellow or white deposits in eyes)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Decreased appetite
Depression
Granulocytopenia (lack of granulocyte)
Hypokalaemia (low potassium)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Neutropenia (an abnormally low number of neutrophils)
Pneumonia

50-59:

Asthenia (weakness)
Delirium (wild excitement)
Diarrhoea
Dizziness
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hyperkalaemia (damage to or disease of the kidney)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
Dysphagia (a condition in which swallowing is difficult or painful)

60+:

Disseminated intravascular coagulation (systemic activation of blood coagulation)
Multi-organ failure (multisystem organ failure)
Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
Kaposi's sarcoma aids related (a tumour caused by human herpes virus associated with aids)
Malaise (a feeling of general discomfort or uneasiness)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Tonic convulsion (the person will quickly lose consciousness and the skeletal muscles will suddenly tense, often causing the extremities to be pulled towards the body or rigidly pushed away from it)
White blood cell count decreased
Hypersensitivity
Hypoxia (low oxygen in tissues)

What are the existing conditions these people have? *

Hiv Infection: 15 people, 28.85%
Mycobacterium Avium Complex Infection: 12 people, 23.08%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 11 people, 21.15%
Pneumonia: 9 people, 17.31%
Pulmonary Tuberculosis (lungs tuberculosis): 7 people, 13.46%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 5 people, 9.62%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 5 people, 9.62%
Diabetes: 5 people, 9.62%
Cytomegalovirus Oesophagitis (oesophagus infection with cytomegalo virus): 5 people, 9.62%
Candidiasis (candidiasis or thrush is a fungal infection): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Rifabutin and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously